| Literature DB >> 20202425 |
Siegbert Rieg1, Tilman Martin Bauer, Gabriele Peyerl-Hoffmann, Jurgen Held, Wolfgang Ritter, Dirk Wagner, Winfried Vinzenz Kern, Annerose Serr.
Abstract
Paenibacillus larvae causes American foulbrood in honey bees. We describe P. larvae bacteremia in 5 injection drug users who had self-injected honey-prepared methadone proven to contain P. larvae spores. That such preparations may be contaminated with spores of this organism is not well known among pharmacists, physicians, and addicts.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20202425 PMCID: PMC3322038 DOI: 10.3201/eid1603.091457
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
FigurePaenibacillus larvae gram-positive, spore-forming, rod-shaped bacteria (A) (Gram stain, original magnification ×1,000) with the ability to form giant whips upon sporulation (B) (nigrosine stain, original magnification ×1,000). In American foulbrood (AFB), newly hatched honey bee larvae become infected through ingestion of brood honey containing P. larvae spores. After germination and multiplication, infected bee larvae die within a few days and are decomposed to a ropy mass, which releases millions of infective spores after desiccation. C) AFB-diseased larvae are beige or brown in color and have diminished segmentation (healthy and AFB-diseased larvae). D) Clinical diagnosis of AFB can be made by a matchstick test, demonstrating the viscous, glue-like larval remains adhering to the cell wall.
Patient characteristics, clinical presentation, treatment, and laboratory and microbiologic results of 5 patients with Paenibacillus larvae bacteremia*
| Characteristic | Patient no. | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Age, y/sex | 28/F | 32/M | 20/M | 35/M | 27/F |
| Date evaluated | 2003 Jul | 2003 Sep | 2003 Oct | 2004 Feb | 2008 May |
| Clinical samples with identification of | Culture of ascites (2003 Jul), blood culture (2003 Aug) | Blood culture | Blood culture | Blood culture | Blood culture |
| CRP, mg/L | 43 | 17 | 11 | 37 | 40 |
| Leukocyte count, × 109/L | 23.0 | 13.0 | 9.3 | 11.8 | 19.2 |
| Medical history | IVDA, hepatitis C, Child B liver cirrhosis with refractory ascites | IVDA, hepatitis C, hepatitis B | IVDA, hepatitis C | IVDA, hepatitis C, history of hepatitis A | IVDA, hepatitis C, alcohol abuse |
| Clinical signs and symptoms | Decompensated liver cirrhosis, ascites, fever (39.2°C) | Persistent weakness and malaise, fever (39.2°C) | Somnolence, fever (38.2°C) | Tachypnoe, right-sided pleuritic chest pain, fever (37.8°C) | Severe anemia, spontaneous mucosal bleeding, fever (39.8°C) |
| Clinical conditions other than bacteremia | Bacterial peritonitis, hepatic encephalopathy after TIPS placement | Acute hepatitis B diagnosed 1 mo before bacteremia, eosinophilia | Methadone/ diazepam overdose | Pulmonary embolism, infarction pneumonia, deep vein thrombosis | Subsequently diagnosed with ITP, |
| Treatment (duration) | Meropenem (7 d) followed by ampicillin IV (2 d), then meropenem (7 d) followed by penicillin G (14 d) | None | None | Cefuroxim IV (7 d) | Imipenem (21 d) |
*CRP, C-reactive protein (reference range <5 mg/L); IVDA, intravenous drug abuse; TIPS, transjugular intrahepatic portosystemic shunt; ITP, idiopathic thrombocytopenic purpura; IV, intravenous. †P. larvae identified after culture using 16S rRNA gene sequencing.